Stanley Druckenmiller
TWST icon

Stanley Druckenmiller’s Twist Bioscience TWST Stock Holding History

Stanley Druckenmiller’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-206,000
Closed -$9.79M – 114
2026
Q1 		$9.79M Buy
+206,000
New +$9.24M 0.29% 56

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Stanley Druckenmiller's TWST Position: Q2 2026 in Review

Stanley Druckenmiller sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 206,000 shares — an estimated $9.79M sold.

Stanley Druckenmiller first reported a position in TWST in Q1 2026 and held it in 1 quarter. The position peaked at $9.79M in Q1 2026. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Stanley Druckenmiller reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Stanley Druckenmiller sold 206,000 Twist Bioscience shares in Q2 2026, an estimated $9.79M.
  • Stanley Druckenmiller first reported a position in Twist Bioscience in Q1 2026 and held it in 1 quarter.
  • Stanley Druckenmiller's Twist Bioscience position peaked at $9.79M in Q1 2026.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Duquesne Family Office's 13F filing for Q2 2026, filed 14 Aug 2026.